Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
11/11/2026 06:01
BRIEF-Hansa Biopharma Q3 Net Income SEK -178.5 Million Nov 11 (Reuters) - Hansa Biopharma Q3 adjusted EPS SEK -1.75.
- Q3 cash & investments SEK 1,337.2 million
- Q3 revenue SEK 143 million
- Q3 EBIT SEK -138.6 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS